Mahamaya Lifesciences IPO GMP, Review, Price, Allotment

Mahamaya Lifesciences IPO Description – Established in 2002, Mahamaya Lifesciences is a leading manufacturer of pesticide formulations, supplying bulk formulations to Indian agrochemical companies and multinational corporations. Initially focused on importing and registering vital pesticide molecules not produced in India, the company secured approvals from the Central Insecticides Board and Registration Committee (CIBRC) before marketing these molecules domestically and internationally.

In December 2021, Mahamaya commissioned its formulation plant at Dahej, Gujarat, enabling production of bulk formulations, branded products, and exports. Domestically, its 300+ dealer network spans Punjab, Haryana, Rajasthan, Uttar Pradesh, Gujarat, and Maharashtra, while exports reach countries such as the Dominican Republic, Turkey, Egypt, and the UAE.

The company emphasizes safer, eco-friendly solutions, including bio-stimulants, plant growth regulators, bio-fertilizers, and low-toxicity bio-fermented pesticides. As of 30 September 2024, Mahamaya employs 65 staff and maintains flexible contract labor to meet operational needs, reinforcing its strong domestic and global market presence.

Mahamaya Lifesciences IPO Allotment Status

Promoters of Mahamaya Lifesciences – Mr. Krishnamurthy Ganesan, Mrs. Lalitha Krishnamurthy, and Mr. Prashant Krishnamurthy

Mahamaya Lifesciences Offer Details

Mahamaya Lifesciences IPO Dates	Coming soon
Mahamaya Lifesciences Issue Price	Coming soon
Fresh Issue	56,38,800 shares
Offer For Sale	5,40,800 shares
Total IPO Size	61,78,800 shares
Minimum Bid	Coming soon
Lot Size	Coming soon
Face Value	INR 10 per share
Individual Allocation	35%
Listing On	BSE SME

Mahamaya Lifesciences Financial Performance

	FY 2022	FY 2023	FY 2024	H1 FY 2025
Revenue	89.91	137.08	161.57	146.23
Expenses	86.43	132.30	155.71	137.17
Net income	2.72	3.75	5.22	7.41

Figures in INR Crores unless specified otherwise

Mahamaya Lifesciences Offer News

Mahamaya Lifesciences Valuations & Margins

	FY 2022	FY 2023	FY 2024
EPS	1.98	2.73	3.80
PE ratio	–	–	–
RONW (%)	17.34	19.29	21.16
NAV	11.43	14.15	17.95
ROCE (%)	18.41	23.34	32.38
EBITDA (%)	6.64	6.49	8.20

*Compiled by IPO Central from Prospectus

Mahamaya Lifesciences IPO GMP Today

Mahamaya Lifesciences IPO Subscription – Live Updates

Coming soon

The market maker reservation portion of () shares and the anchor investor portion of () shares are not included in the above calculations.

Mahamaya Lifesciences IPO Allotment Status

Mahamaya Lifesciences IPO allotment status will be available on the KFin Tech website. Click on this link to get the allotment status.

Mahamaya Lifesciences IPO Dates & Listing Performance

IPO Opening Date	Coming soon
IPO Closing Date	Coming soon
Finalization of Basis of Allotment	Coming soon
Initiation of refunds	Coming soon
Transfer of shares to demat accounts	Coming soon
IPO Listing Date	Coming soon
Opening Price on BSE SME	Coming soon
Closing Price on BSE SME	Coming soon

Mahamaya Lifesciences Offer Lead Manager

ONEVIEW CORPORATE ADVISORS PRIVATE LIMITED
Bajaj Bhawan, Room No. 111, 11th Floor,
Nariman Point, Mumbai – 400021
Phone: +91- 22- 43472247
Email: [email protected]
Website: www.oneviewadvisors.com

Mahamaya Lifesciences Offer Registrar

KFIN TECHNOLOGIES LIMITED
Selenium Tower – B, Plot 31 & 32, Gachibowli,
Financial District, Nanakramguda, Serilingampally,
Hyderabad – 500 032, Telangana
Tel: +91 40 6716 2222
E-mail: [email protected]
Website: www.kfintech.com

MAHAMAYA LIFESCIENCES LIMITED
Unit No: DPT – 033, Ground Floor,
Plot No: 79 – 80, DLF Prime Tower, F-Block,
Okhla, Phase – 1, New Delhi – 110020
Phone: +91-1146561474
E-mail: [email protected]
Website: www.mahamayalifesciences.com